INTRODUCTION
Muscular insulin resistance IR is a characteristic of obesity and leads to the development of type 2 diabetes. Many studies have suggested that intramuscular lipid accumulation contributes to the development of IR 1 3 .
However, well-trained athletes also have high intramuscular triacylglycerol IMTG concentrations, but preserve insulin sensitivity 4, 5 . The molecular mechanisms linking IMTG accumulation and impaired IR have not yet been fully elucidated, although this metabolic paradox indicates that the total amount of IMTGs might not directly impair insulin action. Various studies have demonstrated that saturated fatty acids FAs in skeletal muscle are linked to the insulin signaling cascade 6, 7 . In accordance with this, increased amounts of saturated FAs in skeletal muscles have been found to be associated with IR, whereas polyunsatu-tive unsaturated FAs, i.e., palmitoleic acid C16:1 and oleic acid C18:1 . The upregulation of SCD1 could result in a significant increase in the rate of triacylglycerol TG synthesis and protect against FA-induced IR 9, 10 . Endurance exercise reportedly increases muscular TG synthesis and improves IR by stimulating SCD1 activity in skeletal muscles 11 . Therefore, increasing the proportion of unsaturated FAs in skeletal muscles is thought to be important in improving IR. Thiazolidinediones TZDs , which stimulate peroxisome proliferator receptor gamma PPAR-γ , are known to facilitate the differentiation of adipocytes and generate small adipocytes, resulting in improved muscular IR 12 . PPAR-γ is highly expressed in adipose tissues, but is not abundant in skeletal muscles 13, 14 . However, the activation of PPAR-γ also modifies lipid metabolism and the FA composition of skeletal muscles 15 . Lessard et al. suggested that the proportion of monounsaturated FAs in skeletal muscles is increased by rosiglitazone, a TZD compound 15 . Recently, rosiglitazone was also reported to increase the TG content and SCD indices C18:1/C18:0 ratio of rat oxidative muscles 16 , but little is known about the effects of other
TZDs, e.g., pioglitazone. Some clinical trials have shown that rosiglitazone worsens cardiovascular conditions when compared with pioglitazone 17, 18 . Pioglitazone has not been reported to worsen the risk of cardiovascular disease and has been used for the treatment of type 2 diabetes, although the binding potency of pioglitazone to PPAR-γ is weaker than that of rosiglitazone 19 . However, little is known about the effects of pioglitazone on TG accumulation, FA composition, and SCD indices in several types of skeletal muscles. Blood TG uptake and fat metabolite accumulation in adipose tissues and skeletal muscles are regulated by or related to lipoprotein lipase LPL activity 20 . LPL is a ratelimiting enzyme for TG hydrolysis that regulates the blood TG concentration. Insulin plays an important role in the biosynthesis of LPL, so LPL expression and its function increases with increasing insulin sensitivity 21 . However, it remains unknown which types of skeletal muscles and other tissues are stimulated by pioglitazone, how pioglitazone stimulates LPL activity and fat metabolism, and even whether pioglitazone stimulates LPL activity at all. In this study, we investigated the effects of pioglitazone on fat accumulation, FA composition, SCD indices, and LPL activity in various rat tissues.
MATERIALS AND METHODS

Animals and diets
All procedures involving rats were approved by the Experimental Animal Care Committee of Kagawa University.
Seventeen 3-week-old male Wistar rats were purchased from Japan SLC Shizuoka, Japan . The rats were housed individually at 22 1 with lights on between 08:00 and 20:00 h and given free access to water and food CE-2; Japan CLEA, Tokyo, Japan for 7 days of acclimation. The rats were divided into 2 groups, control group C, n 9 and pioglitazone treatment group P, n 8 , and were fed a high-fat and high-sucrose diet for 8 weeks. 18 .5 stearic acid, 45.9 oleic acid, and 2.7 linoleic acid. The rats were given an oral dose of 3 mg/kg as 5 mL of solution per kg pioglitazone hydrochloride Wako Pure Chemical Industries, Ltd., Osaka, Japan in a 0.5 w/v carboxymethylcellulose sodium salt CMC-Na solution P group and 5 mL/kg of 0.5 CMC-Na C group once a day for 8 weeks. The body weight and dietary intake of each rat were monitored daily.
Oral glucose tolerance test
An oral glucose tolerance test OGTT was performed in the eighth week of the test period. After a 12 h fast, D-glucose 2 g, in 5 mL, per kg was orally administered, and blood was collected from the tail vein before administration and at 30, 60, 90, and 120 min after. The blood was centrifuged at 6200 g for 5 min to obtain the plasma, and stored at 80 until analysis.
Sampling of blood and tissues
At the end of the test period, all of the rats were sacrificed by decapitation after a 12 h fast. Blood was collected and centrifuged at 6200 g for 15 min to obtain the serum. The liver, intra-abdominal adipose tissues perirenal, epididymal, and mesenteric , brown adipose tissue BAT , and skeletal muscles soleus, gastrocnemius, and extensor digitorum longus, EDL were quickly removed, weighed, and frozen in liquid nitrogen. The serum, liver, perirenal adipose tissue, BAT, and muscles were then stored at 80 until analysis.
Analysis
Plasma OGTT glucose levels and serum levels of glucose, non-esterified FAs NEFAs , TGs, and total cholesterol were measured using commercial kits Wako Pure Chemical Industries, Ltd. . Serum adiponectin levels were measured using a commercial enzyme-linked immunosorbent assay ELISA kit Otsuka Pharmaceutical Co., Ltd., Tokyo, Japan . Serum and OGTT plasma insulin levels were measured using commercial ELISA kits Shibayagi Co. Ltd., Gunma, Japan . The total lipids in the liver and skeletal muscles were extracted using the method of Folch et al. 22 .
The TG concentrations in the total lipids from the liver and skeletal muscles were measured using a Triglyceride E-test Wako Kit Wako Pure Chemical Industries, Ltd. . The FA composition of the serum, perirenal adipose tissue, BAT, and TGs from the liver and skeletal muscles was determined using gas chromatography. The liquid in the TG extract was evaporated under a stream of nitrogen gas and then transmethylated with a methanol and sulfuric acid 230:2, v/v mixture. The FA methyl esters were extracted using hexane and separated using a gas chromatograph GC-2014; Shimadzu, Kyoto, Japan equipped with a 30-m capillary column Ulbon HR-20 M; Shimadzu . The column temperature was 210 , and the carrier gas was helium at a flow rate of 0.65 mL min 1 . The methyl esters of individual FAs were identified by comparing their retention times to those of pure methyl esters and then quantified using their peak areas. The LPL activity in the perirenal adipose tissue, BAT, and skeletal muscles was measured using the method of Shimomura et al. 23 . LPL was extracted from the samples using 0.05 M Tris-HCl pH 8.0 containing 1 M ethylene glycol, while the LPL substrate was prepared according to the method of Nilsson-Ehle and Schotz 24 using unlabeled triolein. An LPL activity assay was performed by incubating the extracts with the substrate at 37 for 30 min and measuring the NEFAs released during the incubation calorimetrically using a kit NEFA-C Test Wako; Wako Pure Chemical Industries, Ltd. . One unit of LPL catalyzed the release of 1 µmol NEFA per hour.
Statistical analysis
Each value is expressed as the mean standard error. Differences between the groups were evaluated using Student s t-test. A difference of p 0.05 was considered statistically significant. All statistical analyses were performed using a commercially available software package Excel Statistics 2008; SSRI, Tokyo, Japan .
RESULTS
Body weight, dietary intake, and tissue weight
The body weight, dietary intake, and tissue weight of the rats are shown in Table 1 . Body weight gains and dietary intake were not significantly different between the C and P groups. Relative hepatic weight was significantly lower in the P group than in the C group. The relative weight of the perirenal adipose tissue and BAT was significantly higher in the P group than in the C group. There was no significant difference between the groups for the other tissues.
OGTT
The OGTT glucose and insulin levels are shown in Fig. 1 . The fasting and OGTT plasma glucose levels at 30 min after glucose administration were significantly lower in the P group than in the C group. The OGTT plasma insulin levels at 30, 60, and 120 min after glucose administration were significantly lower in the P group than in the C group.
Serum biochemical components
The serum biochemical-component levels are shown in Table 2 . The serum adiponectin levels were significantly higher in the P group than in the C group. The serum glucose and total cholesterol levels were significantly lower in the P group than in the C group. The TG and NEFA levels were not significantly different between the groups.
TG content in tissues
The TG content in the liver and skeletal muscles is shown in Fig. 2 . The hepatic TG content was significantly lower in the P group than in the C group. In contrast, the TG content in the soleus, gastrocnemius, and EDL muscles was significantly higher in the P group than in the C group. The FA composition of the serum, liver, perirenal adipose tissue, BAT, and skeletal muscles is shown in Table 3 . The palmitic acid percentage in the serum lipids was significantly higher in the P group than in the C group. The other FA percentages in the serum lipids were not significantly different between the groups. The palmitic and oleic acid percentages in the hepatic lipids were significantly lower, while the stearic, linoleic, and arachidonic acid percentages were significantly higher in the P group than in the C group. The palmitic and stearic acid percentages in the perirenal adipose tissues were significantly lower and the palmitoleic and oleic acid percentages were significantly higher in the P group than in the C group. The palmitic acid percentage in BAT was significantly lower and the stearic and linoleic acid percentages were higher in the P group than in the C group. The palmitoleic and oleic acid percentages in the muscular lipids were significantly higher and the palmitic and stearic acid percentages were significantly lower in the P group than in the C group. The FA desaturation indices, i.e., the C16:1/C16:0 and C18:1/C18:0 ratios, for the lipids in the serum and other tissues are shown in Figs. 3 and 4 , respectively. The FA desaturation indices for the muscular lipids were significantly higher in the P group than in the C group. The FA desaturation indices for the perirenal adipose tissues were also significantly higher in the P group than in the C group. The C18:1/C18:0 ratios in the hepatic lipids and BAT were significantly lower in the P group than in the C group. The relationship between TG content and adipose tissue weight with the FA desaturation index C18:1/C18:0 in the soleus muscle, liver, perirenal adipose tissue, and BAT is shown in Fig. 5 . In the soleus muscle and liver, the FA desaturation indices were highly correlated with the TG content; however, this tendency was not seen in BAT.
LPL activity of tissues
The LPL activity of perirenal adipose tissue, BAT, and skeletal muscle is shown in Fig. 6 . The perirenal adipose tissue and BAT LPL activity was significantly higher in the P group than in the C group. There was no significant difference in the LPL activity in the muscles.
DISCUSSION
The repeated administration of pioglitazone increased serum adiponectin levels remarkably and slightly improved glucose tolerance, as reported previously 25 , and it significantly increased fat accumulation in the skeletal muscles, perirenal adipose tissue, and BAT. Pioglitazone also significantly increased the SCD indices for the skeletal muscles and perirenal adipose tissue. As shown in Fig. 5 , fat accumulation and SCD indices were highly correlated in the soleus muscle and slightly correlated in the perirenal adipose tissue, but there was no correlation in BAT. Our 16 demonstrated that the SCD indices in oxidative muscles were increased by PPAR-γ activation.
Fig. 2 Effects of pioglitazone administration on TG contents in liver and muscles Values are means ±SE (n=8-9
).*,*** p < 0.05, 0.001 compared to C group (Student's t-test). Table 3 Effects of pioglitazone administration on FA compositios of serum and tissues. Values are means SE (n=8-9). *, **, *** p <0.05, 0.01, 0.001, respectively compared to C group (Student's t -test) 
-test).
SCD1 plays an important role in skeletal-muscle lipogenesis and that in other tissues, and is expressed abundantly in oxidative muscles 28 . Our results initially showed that TG accumulation and SCD indices were increased by pioglitazone not only in oxidative muscle soleus but also in glycolytic muscle EDL and oxidative-glycolytic muscle gastrocnemius , and adiponectin secretion and glucose tolerance improved. However, the present study could not explain the contradictory result that glucose tolerance was improved by the increased accumulation of muscular TGs. Chabowski et al. 16 showed that TG accumulation in the soleus and red gastrocnemius muscles was significantly increased by the administration of rosiglitazone or endurance exercise training in rats fed a high-fat diet. Their findings induced by PPAR-γ activation were in agreement with our present findings. Chabowski et al. 16 measured the accumulation of muscular fat metabolites TGs, diacylglycerol DG , NEFAs, and phospholipids separately in skeletal muscles and showed that the accumulation of DG and NEFAs in the soleus muscle was significantly decreased by rosiglitazone; however, we did not measure the fat metabolite content in the present study. Several research 6, 29 and review articles 3, 30 suggested that increased muscular TG accumulation was not directly involved in the disruption of the insulin signaling pathway, and the accumulation of other lipid metabolites mainly DG in skeletal muscles was closely related to IR. It is quite well accepted that DG content is increased in IR 6 and reduced by endurance exercise 29 . However, as described previously 16 , whether the reduction in muscular DG by PPAR-γ activation is closely correlated to the improvement of glucose tolerance needs to be further investigated. It has been repeatedly suggested that the excessive accumulation of saturated fat in skeletal muscles is an important factor in the development of IR, and lipotoxicity from fat accumulation is specific to saturated FAs 11, 31, 32 . Gao et al. 31 suggested that oleate protects against palmitate-induced IR in L6 myotubes. Peng et al. 32 suggested that oleate blocked palmitate-induced IR in muscle cells, and Pinnamaneni et al. 9 suggested that increased muscular SCD1 activity resulted in a significant increase in the rate of TG synthesis and protected against FA-induced IR. The pioglitazone-induced increase in the ratio of palmitoleic and oleic acids can be closely associated with the improvement of glucose tolerance in the present study. Muscles, liver, and adipose tissues are important insulinresponsive tissues, and the accumulation of fat metabolites is generally thought to be an important factor related to IR. LPL plays an important role in the hydrolysis of TG-rich lipoproteins and the delivery of blood NEFAs to insulin-responsive tissues. Stimulating LPL activity in muscles is known to increase the concentrations of fat metabolites and worsen IR because of lipotoxicity 33, 34 . Kageyama et al. 35 suggested that pioglitazone selectively increases LPL mRNA expression in white adipose tissues, but not in muscles. The lack of a significant change in LPL production in skeletal muscles caused by pioglitazone could prevent the development of IR because excess NEFAs and TGs in the blood would not be transported to the muscles. This is in agreement with our results, which showed that LPL activity was closely correlated with fat accumulation in BAT and perirenal adipose tissue, but not in the various types of skeletal muscles examined. The LPL activity of the soleus muscle, which contained 3 times more TGs than the other muscles, was not altered by pioglitazone. The serum levels of TGs and NEFAs, serum SCD indices, and LPL activity in the skeletal muscles were not significantly influenced by pioglitazone, indirectly indicating that the uptake of blood TG-derived NEFAs was not stimulated by pioglitazone in the skeletal muscles, and the increased fat accumulation and SCD indices in the skeletal muscles occurred independently. Therefore, the increase in muscular TG content was not caused by the stimulation of muscular LPL activity, but by other mechanisms; however, the detailed mechanisms still need to be elucidated. The increase in LPL activity in the perirenal adipose tissue and BAT can partly explain the increase in adipose tissue weight by pioglitazone, as described by Kageyama et al. 35 .
Some reported results 36 38 do not agree with our findings. Dobrzyn et al. 36 suggested that SCD1 deficiency increased the rate of β-oxidation in oxidative muscles by activating the AMP-activated protein kinase pathway, thus protecting against IR and obesity. Increased SCD1 mRNA expression and SCD indices have been found in IR skeletal muscle from obese humans 37 . Diet-induced weight loss has been found to accompany a reduction in muscle SCD1 protein levels 38 . Considering these controversial data, the role of SCD in IR is important in muscles, but the detailed mechanisms still need to be fully elucidated. SCD1 expression is reportedly abundant and closely related to lipogenesis in the liver 28 . SCD1 deficiency leads to a decrease in hepatic TG contents and downregulates de novo FA synthesis 38, 39 . In our study, the hepatic weight, hepatic TG content, and hepatic SCD indices were closely correlated, and they were all decreased by pioglitazone. In particular, the stearic acid percentage was significantly increased, while the oleic acid percentage was decreased in the hepatic lipids by pioglitazone. The results from the liver clearly contrasted with those from the skeletal muscles and white adipose tissue. Therefore, the regulation of lipogenesis by pioglitazone was tissue specific. In spite of these contrasting results, Kubota et al. 25 suggested that the pioglitazone-induced increased secretion of adiponectin in the blood improved hepatic IR. Toyama et al. 40 showed that a high dose of pioglitazone 30 mg/kg improved IR, but did not alter the serum and liver SCD indices. These findings suggest that the hepatic SCD index is not responsible for the improvements in IR. Therefore, there are still conflicting findings regarding the effects of pioglitazone on SCD function in the liver.
In conclusion, the repeated administration of low levels of pioglitazone for 8 weeks improved glucose tolerance and increased fat accumulation and SCD indices in adipose tissues and oxidative and glycolytic skeletal muscles in rats. The increase in fat accumulation induced by pioglitazone was closely correlated with LPL activity in adipose tissues, but did not correlate with LPL activity in the skeletal muscles.
